Eagle Pharmaceuticals
EGRX
#10135
Rank
โ‚น0.69 B
Marketcap
โ‚น53.67
Share price
-11.43%
Change (1 day)
-84.80%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): โ‚น2.93 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.25 Billion. In 2022 the company made an earning of โ‚น5.70 Billion, an increase over its 2021 earnings that were of -โ‚น0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚น2.93 B-48.47%
2022 โ‚น5.70 B-2361.45%
2021 -โ‚น0.26 Billion-111.53%
2020 โ‚น2.18 B2.31%
2019 โ‚น2.13 B-32.89%
2018 โ‚น3.18 B-50.35%
2017 โ‚น6.41 B38.63%
2016 โ‚น4.62 B1966.43%
2015 โ‚น0.22 B-111.46%
2014 -โ‚น1.96 Billion282.82%
2013 -โ‚น0.52 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น1.592 T 51,485.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น361.04 B 11,596.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น1.102 T 35,604.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น36.35 B 1,077.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น405.03 B 13,021.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น878.66 B 28,365.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น595.57 Billion-19,393.87%๐Ÿ‡บ๐Ÿ‡ธ USA